title: Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin).
authors.forename: N
authors.initials: N
authors.lastname: Kenawy
authors.forename: C
authors.initials: C
authors.lastname: Groenwald
authors.forename: B
authors.initials: B
authors.lastname: Damato
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008875:Middle Aged; D009383:Neoplasms, Vascular Tissue / Q000188:drug therapy*; D019572:Retinal Neoplasms / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab